TrialJournal of critical care2022

A pilot, feasibility, randomised controlled trial of midodrine as adjunctive vasopressor for low-dose vasopressor-dependent hypotension in intensive care patients: The MAVERIC study.

Rahul Costa-Pinto et al.PubMed ↗Publisher ↗

No numbers read from the abstract.